Difference between revisions of "IVAX Corporation"
Line 1: | Line 1: | ||
− | < | + | The Ivax Corporation is a huge Florida-based health company. [[Norton Healthcare]], the largest generic drugs company in Britain, is a subsidiary of IVAX. [[Isaac Kaye]] earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.<ref>Ref needed</ref>. In 2006 IVAX was aquired by [[Teva]] which is described as 'Israel's largest company'.<ref>Teva, [http://www.tevapharm.com/financial/teva-ivax.asp IVAX Acquisition], accessed 23 May 2008</ref> The aquisition is reported to have created 'the world's largest generics company'.<ref>Maguire K (2002) [http://www.guardian.co.uk/uk/2002/apr/13/politics.partyfunding Profile:Isaac Kaye] <i>The Guardian</i> 13th April 2002. Accessed 4th April 2008</ref>. |
+ | Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003<ref>Brogan, B. & Gysin, C. (2008) Hain faces sack in sleaze inquiry; He could be barred - but Brown might fire him first. <i>The Daily Mail</i> (London). 12th January 2008</ref>. <i>Plunkett's Health Care Industry Almanac</i> reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively. | ||
+ | |||
+ | ==People== | ||
+ | *[[Isaac Kaye]] | ||
==Aquisitions== | ==Aquisitions== | ||
In 2004, IVAX is reported to have aquired [[ChemSource Corporation]] (which is based in Puerto Rico)<ref> <i>Plunkett's Health Care Industry Almanac</i>. 'IVAX Corporation.' January 2004</ref> . | In 2004, IVAX is reported to have aquired [[ChemSource Corporation]] (which is based in Puerto Rico)<ref> <i>Plunkett's Health Care Industry Almanac</i>. 'IVAX Corporation.' January 2004</ref> . | ||
Line 9: | Line 13: | ||
==Brands, Divisions and Affiliates== | ==Brands, Divisions and Affiliates== | ||
+ | *[[Norton Hea | ||
In 2004, <i>Plunkett's Health Care Industry Almanac</i> reports the following 'Brands/Divisions/Affiliates' of IVAX<ref> <i>Plunkett's Health Care Industry Almanac</i>. 'IVAX Corporation.' January 2004</ref>... | In 2004, <i>Plunkett's Health Care Industry Almanac</i> reports the following 'Brands/Divisions/Affiliates' of IVAX<ref> <i>Plunkett's Health Care Industry Almanac</i>. 'IVAX Corporation.' January 2004</ref>... | ||
* [[Airmax]] | * [[Airmax]] |
Revision as of 06:32, 23 May 2008
The Ivax Corporation is a huge Florida-based health company. Norton Healthcare, the largest generic drugs company in Britain, is a subsidiary of IVAX. Isaac Kaye earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.[1]. In 2006 IVAX was aquired by Teva which is described as 'Israel's largest company'.[2] The aquisition is reported to have created 'the world's largest generics company'.[3].
Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003[4]. Plunkett's Health Care Industry Almanac reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively.
People
Aquisitions
In 2004, IVAX is reported to have aquired ChemSource Corporation (which is based in Puerto Rico)[5] .
ChemSource is reported to have 'recently entered into a license agreement with Novartis Pharma AG to utilize the patented multi-dose dry powder inhaler, Airmax, for Novartis's trademarked medicines Foradil and Miflonide in the European Union and certain other countries'[6].
In July 2003, Business Wire reports that IVAX 'received the first of a series of payments from B Braun Melsungen AG, under a number of agreements, for certain patent and product rights and for settlement of litigation'[7].
Brands, Divisions and Affiliates
- [[Norton Hea
In 2004, Plunkett's Health Care Industry Almanac reports the following 'Brands/Divisions/Affiliates' of IVAX[8]...
- Airmax
- Easi-Breathe
- Paxene
- Paxoral
- TP-38
- ChemSource Corporation
- IVAX Pharmaceuticals Inc.
- Novartis Pharma AG
References
- ↑ Ref needed
- ↑ Teva, IVAX Acquisition, accessed 23 May 2008
- ↑ Maguire K (2002) Profile:Isaac Kaye The Guardian 13th April 2002. Accessed 4th April 2008
- ↑ Brogan, B. & Gysin, C. (2008) Hain faces sack in sleaze inquiry; He could be barred - but Brown might fire him first. The Daily Mail (London). 12th January 2008
- ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
- ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
- ↑ Business Wire 'IVAX Reports Increased Revenues and Net Income for 2nd Quarter of 2003; 2Q2003 Net Revenues Up 22% to $343 Million, Net Income Up 30% to $41.3 Million' 30th July 2003. Miami
- ↑ Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004